Kevin J. McNamara, President and CEO of Chemed Corporation, filed a Form 4 on August 24, 2026, disclosing the sale of 2,000 shares of Chemed Capital Stock on August 21, 2026.

Key Highlights

  • Shares sold: McNamara disposed of 2,000 shares of Chemed Capital Stock on August 21, 2026.
  • Weighted average price: The reported sale price was $541.16 per share, a weighted average across multiple transactions.
  • Price range: Individual transactions occurred at prices ranging from $539.62 to $542.53 per share.
  • Remaining ownership: Following the sale, McNamara directly holds 70,418 shares of Capital Stock.
  • Reporting person role: McNamara is identified as both a Director and Officer (President and CEO) of Chemed Corporation.

McNamara's August 2026 Stock Sale: Transaction Details and Remaining Holdings

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Kevin J. McNamara, President and CEO of Chemed Corporation (NYSE:CHE), sold 2,000 shares of the company's Capital Stock on August 21, 2026. The filing records the transaction under code "S," indicating an open-market sale. The shares were disposed of directly, and the filing notes no derivative securities transactions.

The filing discloses that the $541.16 price per share is a weighted average, as the shares were sold across multiple transactions at prices ranging from $539.62 to $542.53. According to the filing, McNamara "undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4." Following the reported transaction, McNamara's direct beneficial ownership stands at 70,418 shares of Capital Stock.

The Form 4 was filed by one reporting person on August 24, 2026, with August 21, 2026 listed as the date of the earliest transaction. No amendment date is indicated, and Table II, covering derivative securities, contains no reported transactions.

What Was Disclosed

The filing reports the direct sale of 2,000 shares of Chemed Capital Stock by President and CEO Kevin J. McNamara at a weighted average price of $541.16, with individual trades ranging from $539.62 to $542.53, leaving him with 70,418 shares directly held.